Literature DB >> 15517626

Association of reduced CD4 T cell responses specific to varicella zoster virus with high incidence of herpes zoster in patients with systemic lupus erythematosus.

Hyung-Bae Park1, Ki-Chan Kim, Jae-Hong Park, Tae-Young Kang, Hye-Soon Lee, Tae-Hwan Kim, Jae-Bum Jun, Sang-Cheol Bae, Dae-Hyun Yoo, Joe Craft, Sungsoo Jung.   

Abstract

OBJECTIVE: To examine whether the high incidence of herpes zoster in patients with systemic lupus erythematosus (SLE) is associated with the frequency of memory T cells specific to varicella zoster virus (VZV).
METHODS: Whole blood samples from 47 subjects [24 patients with SLE, 11 with rheumatoid arthritis (RA) as a disease control, and 12 healthy negative controls] were stimulated with VZV antigen, stained for surface CD4 and CD8 and intracellularly stained for the cytokines interferon-gamma (IFN-gamma), tumor necrosis factor-alpha (TNF-alpha), interleukin 4 (IL-4), and IL-10, followed by flow cytometry analyses. Correlations of VZV-specific T cell frequencies with the clinical status of patients were analyzed.
RESULTS: Percentage of IFN-gamma-positive CD4 T cells was significantly lower in patients with SLE (0.043 +/- 0.009%) than in RA (0.102 +/- 0.019%) and healthy controls (0.126 +/- 0.025%) upon VZV stimulation. A similar pattern was seen in TNF-alpha-positive CD4 T cell responses. These low frequencies of VZV-specific CD4 T cells in patients with SLE were significantly related with disease activity (r = -0.435, p = 0.043).
CONCLUSION: These data suggest that the high incidence of herpes zoster in patients with SLE was related to the intrinsic defects in controlling VZV reactivation, and thus VZV-specific CD4 T cell frequency could be another practical risk factor of herpes zoster in patients with SLE.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15517626

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  14 in total

1.  Robust gene expression changes in the ganglia following subclinical reactivation in rhesus macaques infected with simian varicella virus.

Authors:  Nicole Arnold; Christine Meyer; Flora Engelmann; Ilhem Messaoudi
Journal:  J Neurovirol       Date:  2017-03-20       Impact factor: 2.643

2.  Longitudinal analysis of varicella-zoster virus-specific antibodies in systemic lupus erythematosus: No association with subclinical viral reactivations or lupus disease activity.

Authors:  C Rondaan; C C van Leer; S van Assen; H Bootsma; K de Leeuw; S Arends; N A Bos; J Westra
Journal:  Lupus       Date:  2018-04-18       Impact factor: 2.911

3.  The case for Zostavax vaccination in systemic lupus erythematosus.

Authors:  Abigail R Cogman; Eliza F Chakravarty
Journal:  Vaccine       Date:  2013-06-03       Impact factor: 3.641

Review 4.  Immunodeficiency and autoimmunity: lessons from systemic lupus erythematosus.

Authors:  Alexandros P Grammatikos; George C Tsokos
Journal:  Trends Mol Med       Date:  2011-12-15       Impact factor: 11.951

5.  Varicella zoster virus glycoprotein E-specific CD4+ T cells show evidence of recent activation and effector differentiation, consistent with frequent exposure to replicative cycle antigens in healthy immune donors.

Authors:  G N Malavige; L Jones; A P Black; G S Ogg
Journal:  Clin Exp Immunol       Date:  2008-03-20       Impact factor: 4.330

6.  Distinctive Roles for Type I and Type II Interferons and Interferon Regulatory Factors in the Host Cell Defense against Varicella-Zoster Virus.

Authors:  Nandini Sen; Phillip Sung; Arjun Panda; Ann M Arvin
Journal:  J Virol       Date:  2018-10-12       Impact factor: 5.103

7.  Herpes zoster vaccination in SLE: a pilot study of immunogenicity.

Authors:  Joel M Guthridge; Abigail Cogman; Joan T Merrill; Susan Macwana; Krista M Bean; Tiny Powe; Virginia Roberts; Judith A James; Eliza F Chakravarty
Journal:  J Rheumatol       Date:  2013-09-15       Impact factor: 4.666

8.  Increased Risk of Herpes Zoster in Diabetic Patients Comorbid with Coronary Artery Disease and Microvascular Disorders: A Population-Based Study in Taiwan.

Authors:  Chi-Chen Ke; Hui-Chin Lai; Ching-Heng Lin; Chih-Jen Hung; Der-Yuan Chen; Wayne H-H Sheu; Ping-Wing Lui
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

9.  Herpes zoster in patients with systemic lupus erythematosus: Clinical features, complications and risk factors.

Authors:  Dongying Chen; Hao Li; Jingyi Xie; Zhongping Zhan; Liuqin Liang; Xiuyan Yang
Journal:  Exp Ther Med       Date:  2017-10-12       Impact factor: 2.447

10.  IE63-specific T-cell responses associate with control of subclinical varicella zoster virus reactivation in individuals with malignancies.

Authors:  G N Malavige; L T Rohanachandra; L Jones; L Crack; M Perera; N Fernando; D Guruge; G S Ogg
Journal:  Br J Cancer       Date:  2010-01-19       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.